Dr. Patrick Soon-Shiong, who founded two drug companies, including Abraxis BioScience, has started a new company named NantOmics to change the way cancer is treated. The company aims to create a convergence of genomics technology and social networks to amass and manage data that leads to personalized treatment with kinase inhibitors. Under the NantOmics model, cancer will be treated based not on where it is in the body but on its genetic composition.

Related Summaries